UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.8B
| – | – |
0
| – | – |
|
727
Alexandria Real Estate Equities
ARE
$8.79B
| $16.6M | 0.02% |
189,559
+71,235
| +60% | +$6.61M |
|
728
Marvell Technology
MRVL
$199B
| $16.5M | 0.02% |
1,253,579
-137,561
| -10% | -$1.97M |
|
729
OGE Energy
OGE
$9.8B
| $16.5M | 0.02% |
576,599
+9,409
| +2% | +$293K |
|
730
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.02B
| $16.4M | 0.02% |
555,147
+34,338
| +7% | +$1.03M |
|
|
FLTX
731
DELISTED
Fleetmatics Group PLC
FLTX
| $16.4M | 0.02% |
350,203
-38,567
| -10% | -$1.71M |
|
732
A.O. Smith
AOS
$8.48B
| $16.3M | 0.02% |
453,992
-380,714
| -46% | -$13.1M |
|
733
Toll Brothers
TOL
$14.3B
| $16.3M | 0.02% |
427,448
+8,216
| +2% | +$308K |
|
734
Novartis
NVS
$292B
| $16.3M | 0.02% |
184,755
+4,768
| +3% | +$437K |
|
735
HDFC Bank
HDB
$123B
| $16.3M | 0.02% |
1,075,332
-5,432
| -0.5% | -$78.9K |
|
736
SEI Investments
SEIC
$12.6B
| $16.2M | 0.02% |
331,065
+1,017
| +0.3% | +$47.8K |
|
737
United Therapeutics
UTHR
$22B
| $16.2M | 0.02% |
93,173
+57,901
| +164% | +$10.4M |
|
738
CNX Resources
CNX
$5.3B
| $16.2M | 0.02% |
893,426
+2,342
| +0.3% | +$56K |
|
739
Brixmor Property Group
BRX
$9.62B
| $16M | 0.02% |
693,309
+449,663
| +185% | +$11M |
|
|
RGLS
740
DELISTED
Regulus Therapeutics
RGLS
| $16M | 0.02% |
12,181
+3,036
| +33% | +$4.9M |
|
|
ULTI
741
DELISTED
Ultimate Software Group Inc
ULTI
| $15.8M | 0.02% |
96,216
+2,291
| +2% | +$387K |
|
742
W.P. Carey
WPC
$16.5B
| $15.7M | 0.02% |
272,756
-8,729
| -3% | -$546K |
|
|
HCBK
743
DELISTED
HUDSON CITY BANCORP INC
HCBK
| $15.4M | 0.01% |
1,560,140
+2,452
| +0.2% | +$23.7K |
|
744
Warner Bros
WBD
$65.6B
| $15.4M | 0.01% |
462,298
-10,162
| -2% | -$335K |
|
|
MBT
745
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $15.3M | 0.01% |
1,561,876
+141,500
| +10% | +$1.55M |
|
746
Chord Energy
CHRD
$7.75B
| $15.2M | 0.01% |
960,582
+27,752
| +3% | +$467K |
|
747
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
| – | – |
0
| – | – |
|
748
Norwegian Cruise Line
NCLH
$9.25B
| $15.1M | 0.01% |
269,246
+77,598
| +40% | +$4.17M |
|
|
LHO
749
DELISTED
LaSalle Hotel Properties
LHO
| $15M | 0.01% |
423,948
+37,900
| +10% | +$1.4M |
|
750
iShares MSCI Pacific ex Japan ETF
EPP
$2.26B
| $15M | 0.01% |
346,188
+2,870
| +0.8% | +$133K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.